ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
Dow Jones
41.488,19
1,65%
Euro vs US Dollar
1,09165
0,00%
Bitcoin
83.146,36
-1,42%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Supernus Pharmaceuticals Inc (SUPN) Börsenkurse

Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc (SUPN)

NASDAQ
31,26
0,09
(0,29%)
Geschlossen 16 März 9:00PM
Verzögert um 15 Minuten
31,26
0,00
(0,00%)
Nach Börsenschluss: 9:16PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
31,26
Gebot
23,90
Fragen
43,00
Volumen
526.106
31,11 Tagesbereich 31,57
25,53 52-Wochen-Bereich 40,28
Marktkapitalisierung
1,743B
Handelsende
31,17
Handelsbeginn
31,31
Letzte Trade
19307
@
31.26
(priorref)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 16.494.655
VWAP
31,3523
Durchschnittliches Volumen (3 Mio.)
549.957
Ausgegebene Aktien
55.743.095
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
23,59
Gewinn pro Aktie (EPS)
1,33
Erlöse
667,93M
Nettogewinn
73,87M

Über Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812... Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.supernus.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Supernus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SUPN. The last closing price for Supernus Pharmaceuticals was US$31,17. Over the last year, Supernus Pharmaceuticals shares have traded in a share price range of US$ 25,53 to US$ 40,28.

Supernus Pharmaceuticals currently has 55.743.095 shares in issue. The market capitalisation of Supernus Pharmaceuticals is US$1,74 billion. Supernus Pharmaceuticals has a price to earnings ratio (PE ratio) of 23.59.

SUPN Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
11 März 2025
SUPN (0,29%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 März 2025
SUPN (0,29%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 März 2025
SUPN (0,29%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 März 2025
SUPN (0,29%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 März 2025
SUPN (0,29%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 März 2025
SUPN (0,29%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 März 2025
SUPN (0,29%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
26 Februar 2025
SUPN (0,29%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.46-1.4501891551131.7232.9330.7995993731.83065698CS
4-8.33-21.040666835139.5939.9930.3788605832.77312201CS
12-4.16-11.744776962235.4240.2830.3754995734.91155652CS
26-0.08-0.25526483726931.3440.2829.7443410434.75409365CS
52-3.14-9.1279069767434.440.2825.5346596432.17980021CS
156-0.02-0.063938618925831.2842.0921.9942744232.06169877CS
26016.26108.41542.0913.1245652829.36210679CS

SUPN - Frequently Asked Questions (FAQ)

What is the current Supernus Pharmaceuticals share price?
The current share price of Supernus Pharmaceuticals is US$ 31,26
How many Supernus Pharmaceuticals shares are in issue?
Supernus Pharmaceuticals has 55.743.095 shares in issue
What is the market cap of Supernus Pharmaceuticals?
The market capitalisation of Supernus Pharmaceuticals is USD 1,74B
What is the 1 year trading range for Supernus Pharmaceuticals share price?
Supernus Pharmaceuticals has traded in the range of US$ 25,53 to US$ 40,28 during the past year
What is the PE ratio of Supernus Pharmaceuticals?
The price to earnings ratio of Supernus Pharmaceuticals is 23,59
What is the cash to sales ratio of Supernus Pharmaceuticals?
The cash to sales ratio of Supernus Pharmaceuticals is 2,61
What is the reporting currency for Supernus Pharmaceuticals?
Supernus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Supernus Pharmaceuticals?
The latest annual turnover of Supernus Pharmaceuticals is USD 667,93M
What is the latest annual profit for Supernus Pharmaceuticals?
The latest annual profit of Supernus Pharmaceuticals is USD 73,87M
What is the registered address of Supernus Pharmaceuticals?
The registered address for Supernus Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Supernus Pharmaceuticals website address?
The website address for Supernus Pharmaceuticals is www.supernus.com
Which industry sector does Supernus Pharmaceuticals operate in?
Supernus Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
SUPN
Supernus Pharmaceuticals
NASDAQ
ZAANCX
Aavishkaar India Fund Vi
AMEX
DLS
WisdomTree International...
TG
A3LKJP
General Motors Financial
BITMOT
889469
Eib Tf 1,25% Fb31 Usd
BIT
1EA
El Arts Inc Dl 01
BOV
MXRF12
Maxi Renda Fundo Invest ...
BIT
MDA
Lyxor Index Fund-lyxor S...
BIT
ZUC
Vincenzo Zucchi
NYSE
BCO
Brinks
NASDAQ
ZM
Zoom Communications
NASDAQ
ON
ON Semiconductor
NYSE
BFH
Bread Financial
NYSE
ZPIN
Zhaopin Limited
BIT
1SQ
Block
FX
EURMKD
Euro vs MKD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten